Public-registry site landscape for NCT03639883, a Scar study sponsored by AiViva BioPharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03639883 (registry record) |
| Sponsor | AiViva BioPharma, Inc. |
| Condition(s) | Scar; Incision; Abdominal; Wound (Morphologic Abnormality) |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 2 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03639883 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →